Efficacy and safety of recombinant human thrombomodulin for the patients with coagulopathy before cardiovascular surgery
Not Applicable
- Conditions
- aortic aneurysm
- Registration Number
- JPRN-UMIN000010632
- Lead Sponsor
- Yutaka Okita
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients showing intracranial, pulmonary or gastrointestinal hemorrhage. 2) Patients with serious hepatopathy such as fulminant hepatitis, uncompensated liver cirrhosis and others 3) Patients with a history of hypersensitivity to rTM. 4) Pregnant women, nursing mothers or possibly pregnant women.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method DIC score (at the day-6 after the commence of the treatment)
- Secondary Outcome Measures
Name Time Method Blood clotting test findings (FDP, Ddimer, TAT, PIC) AT activity CRP